Major pharmaceutical companies are racing to launch breakthrough drugs in the next  months to treat advanced melanoma the deadliest form of skin cancer  BristolMyers Squibb Co Roche Holding AG and Merck  Co each are working on a potential blockbuster immunotherapy drug that would use the bodys immune system to fight the cancer If approved the three drugs could be launched between late  and late  AstraZeneca PLC has an earlierstage candidate in development